TITLE

FDA considering restricted access to 'abortion pill.'

AUTHOR(S)
Sibbald, Barbara
PUB. DATE
September 2000
SOURCE
CMAJ: Canadian Medical Association Journal;9/05/2000, Vol. 163 Issue 5, p586
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports that mifepristone, or RU-486, a controversial pill that initiates abortion, is being considered for distribution in the United States. Proposal by the U.S. Food and Drug Administration for doctors to prescribe the drug; View of Anne Burnett of the Planned Parenthood Federation of Canada that the drug is needed to ensure women's health.
ACCESSION #
3556215

 

Related Articles

  • A little pill but a big dispute. Whitman, David; Schultz, Stacey // U.S. News & World Report;10/09/2000, Vol. 129 Issue 14, p18 

    Reports on the United States Food and Drug Administration's (FDA) approval of the abortion pill known as RU-486. Possible effect of the drug approval on the United States presidential election between Vice President Al Gore and Texas Governor George W. Bush; History of RU-486, or mifepristone,...

  • The Long, Winding Road of RU-486. Check, Erika // Newsweek;10/2/2000, Vol. 136 Issue 14, p50 

    Reports on the possible approval of the RU-486, or mifepristone drug, by the United States Food and Drug Administration. Studies of the drug which indicate that it can safely end pregnancy; Combination of misoprostol and mifepristone, which induces contractions and causes women to miscarry;...

  • The Long, Winding Road of RU-486. Check, Erika // Newsweek (Atlantic Edition);10/02/2000 (Atlantic Edition), Vol. 136 Issue 14, p51 

    Reports on the possible approval of the drug RU-486, or mifepristone, by the United States Food and Drug Administration. Studies of the drug which indicate that it can safely end pregnancy; Combination of misoprostol and mifepristone, which induces contractions and causes women to miscarry;...

  • The Long, Winding Road of RU-486. Check, Erika // Newsweek (Pacific Edition);10/02/2000 (Pacific Edition), Vol. 136 Issue 14, p41 

    Reports on the possible approval of the drug RU-486, or mifepristone, by the United States Food and Drug Administration. Studies of the drug which indicate that it can safely end pregnancy; Combination of misoprostol and mifepristone, which induces contractions and causes women to miscarry;...

  • Abortion pill is approved for sale in United States. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);10/07/2000, Vol. 321 Issue 7265, p851 

    Reports on the United States Food and Drug Administration's (FDA) approval of the drug RU-486 (mifepristone) for the termination of early pregnancy. Views of politicians and organizations advocating and opposing the FDA decision; Physiological effect of mifepristone; Terms of the FDA approval.

  • Sensitive benefit issues attend RU-486 approval. Lee, Karen // Employee Benefit News;Dec2000, Vol. 14 Issue 14, p11 

    Explores the employee benefits issues related to the approval of the abortion drug mipefristone or RU-486 by the United States Food and Drug Administration. Impact of the procedural and administrative requirements of mipefristone on gynecologists' acceptance of the drug; Some of the legislative...

  • Why France has the abortion pill and we don't. Thomas, Dana // Self;Jan94, Vol. 16 Issue 1, p78 

    Discusses the safety aspects of the French abortion pill RU-486. Success of the abortion pill in Europe; Potential of the pill in treatment of ailments that afflict American women; Approval by the United States Food and Drug Administration (FDA) of the abortion pill; How the pill works;...

  • Safety of RU-486 Is Questionable. Taylor, Stephanie K. // Insight on the News;01/29/2001, Vol. 17 Issue 4, p16 

    Deals with the criticisms on the accelerated approval of the abortion-inducing drug RU-486 or mifepristone by the United States Food and Drug Administration (FDA). Requirements for a drug to qualify for accelerated-approval process of the FDA; Adverse effects of the drug according to clinical...

  • A Revealing Pill. Decter, Midge // Human Life Review;Fall2000, Vol. 26 Issue 4, p143 

    Comments on the approval of the medication mifepristone or RU-486 by the United States Food and Drug Administration. Percentage of women that will have a complete abortion by combining mifepristone and misoprostal; Distinction of the pill from the curette; Advertisement for the RU-486 pill in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics